CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
Malignant central nervous system tumors are the leading cause of cancer death in children. Progress in high-throughput molecular techniques has increased the molecular understanding of these tumors, but the outcomes are still poor. Even when efficacious, surgery, radiation, and chemotherapy cause ne...
Enregistré dans:
Auteurs principaux: | Pauline Thomas, Natacha Galopin, Emma Bonérandi, Béatrice Clémenceau, Sophie Fougeray, Stéphane Birklé |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ae313db6a6094e169834075363a59a1f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Growing Relevance of Immunoregulation in Pediatric Brain Tumors
par: Viktoria Melcher, et autres
Publié: (2021) -
An atypical teratoid/rhabdoid tumor (AT/RT) with molecular features of pleomorphic xanthoastrocytoma (PXA) in a 62-year-old patient
par: Matthias Dottermusch, et autres
Publié: (2021) -
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma
par: Nguyen Minh Duc
Publié: (2021) -
Liquid Biopsy and Primary Brain Tumors
par: Robert H. Eibl, et autres
Publié: (2021) -
CAR-T and other adoptive cell therapies for B cell malignancies
par: Peihua Lu, et autres
Publié: (2021)